DENVER, Oct. 14, 2022 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Friday, October 28, 2022, at 8:30 a.m. Eastern Time. The company plans to release its results before market open the same day.

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:

Friday, October 28, 2022

Starting at 8:30 a.m. ET

Webcast can be accessed using this link

Dial in number: 877-918-6630

International dial in: 517-308-9042

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

About DaVita Inc.

DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2022, DaVita served 198,000 patients at 2,808 outpatient dialysis centers in the United States. The company also operated 349 outpatient dialysis centers in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact Information

Investors:

IR@davita.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-3rd-quarter-2022-investor-conference-call-301649311.html

SOURCE DaVita

DaVita Inc. Schedules 3rd Quarter 2022 Investor Conference Call